| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $33.3M | +63.1% |
| SG&A Expense | $10.3M | +3.4% |
| Operating Income | -$45.5M | -49.6% |
| Interest Expense | $10K | +14.7% |
| Pre-tax Income | -$45.1M | -37.8% |
| Income Tax | -$2.9M | — |
| Net Income | -$42.2M | -29.0% |
| EPS (Basic) | -$0.59 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Current Assets | $56.5M | -42.0% |
| Total Assets | $60.2M | -41.8% |
| Current Liabilities | $7.9M | -3.9% |
| Total Liabilities | $10.4M | -1.6% |
| Stockholders' Equity | $49.9M | -46.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.0M | -12.0% |
| Capital Expenditures | $16K | -87.5% |
| Investing Cash Flow | -$14K | +89.2% |
| Financing Cash Flow | -$5.1M | -106.3% |
| Free Cash Flow | -$35.0M | -11.6% |
| -25.5% |
| EPS (Diluted) | -$0.59 | -25.5% |